Treatment of osteoporosis in postmenopausal women and men
Who takes it
Adults · Children
Adult dose
Take 1 tablet of this medicine (70 mg/2800 IU or 70 mg/5600 IU) once weekly in the morning with a sufficient amount of water, at least 30 minutes before consuming food, beverages, or other medicines. The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly.
The appropriate duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on clinical data from 4 years. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. In patients at low risk of fracture, discontinuation should be considered after 3~5 years of treatment. The fracture risk of patients who discontinue treatment should be reassessed regularly.
Taking food within 30 minutes after taking this medicine, or at the same time, may reduce the absorption of alendronate in the body and decrease its effect. Take this medicine as soon as you get up in the morning and swallow it with a sufficient amount of water (170∼230 mL) to help the medicine reach the stomach quickly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking this medicine and until after the first food intake. Do not take this medicine at bedtime or before getting up in the morning.
Patients whose dietary intake of calcium and vitamin D is insufficient should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic illnesses) may need additional vitamin D supplements. Patients with gastrointestinal malabsorption syndrome may need higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered.
The recommended daily intake of vitamin D is 400 IU to 800 IU. Taking this medicine once weekly provides a week's supply of vitamin D at daily amounts of 400 IU and 800 IU.
If a patient taking 1 tablet of this medicine forgets to take it on the scheduled day, they should take 1 tablet the next morning, resume taking it on the previously scheduled day, and then continue taking it regularly once weekly. However, do not take 2 tablets on the same day.
Use in elderly patients (65 years or older): No dose adjustment is necessary.
No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 35∼60 mL/min). However, administration of this medicine is not recommended in patients with severe renal impairment (creatinine clearance less than 35 mL/min), because clinical experience is insufficient.
Child dose
Children and adolescents (under 18 years of age): The safety and efficacy in children and adolescents have not been established.
Treatment of osteoporosis in postmenopausal women and men
Osteoporosis
View approved original textHide original text
This medication is used for the treatment of osteoporosis in postmenopausal women and men. Osteoporosis is a condition characterized by a decrease in bone density, which increases the risk of fractures. This medication helps strengthen bones and prevent fractures.
How to take
Adult dose
Take 1 tablet of this medicine (70 mg/2800 IU or 70 mg/5600 IU) once weekly in the morning with a sufficient amount of water, at least 30 minutes before consuming food, beverages, or other medicines. The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly.
The appropriate duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on clinical data from 4 years. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. In patients at low risk of fracture, discontinuation should be considered after 3~5 years of treatment. The fracture risk of patients who discontinue treatment should be reassessed regularly.
Taking food within 30 minutes after taking this medicine, or at the same time, may reduce the absorption of alendronate in the body and decrease its effect. Take this medicine as soon as you get up in the morning and swallow it with a sufficient amount of water (170∼230 mL) to help the medicine reach the stomach quickly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking this medicine and until after the first food intake. Do not take this medicine at bedtime or before getting up in the morning.
Patients whose dietary intake of calcium and vitamin D is insufficient should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic illnesses) may need additional vitamin D supplements. Patients with gastrointestinal malabsorption syndrome may need higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered.
The recommended daily intake of vitamin D is 400 IU to 800 IU. Taking this medicine once weekly provides a week's supply of vitamin D at daily amounts of 400 IU and 800 IU.
If a patient taking 1 tablet of this medicine forgets to take it on the scheduled day, they should take 1 tablet the next morning, resume taking it on the previously scheduled day, and then continue taking it regularly once weekly. However, do not take 2 tablets on the same day.
Use in elderly patients (65 years or older): No dose adjustment is necessary.
No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 35∼60 mL/min). However, administration of this medicine is not recommended in patients with severe renal impairment (creatinine clearance less than 35 mL/min), because clinical experience is insufficient.
Child dose
Children and adolescents (under 18 years of age): The safety and efficacy in children and adolescents have not been established.
Precautions
This medication can irritate the stomach and esophagus, leading to problems such as esophagitis, esophageal ulcers, and esophageal erosion. It should be taken with a sufficient amount of water, and you should not lie down for at least 30 minutes after taking it. If you have difficulty swallowing or experience symptoms such as throat pain or heartburn, stop taking the medication immediately and consult your doctor. Patients with esophageal problems, those who cannot sit or stand, or those with hypocalcemia should not take this medication. Gastrointestinal discomfort, abdominal pain, nausea, constipation, diarrhea may occur during use, and in rare cases, skin rashes or severe pain may occur. In particular, if bone, muscle, or joint pain worsens, medical consultation is needed. This medication may lose its effectiveness if taken with calcium supplements, antacids, or certain other medications, so it should be spaced apart in dosing. Additionally, caution is warranted when used in conjunction with non-steroidal anti-inflammatory drugs due to an increased risk of gastrointestinal irritation. Pregnant or breastfeeding women, or children, should consult with a doctor before use. Patients with kidney issues should consult a healthcare professional before using this medication, and elderly patients should exercise caution. In the case of overdose, hypocalcemia and gastrointestinal disturbances may occur, and immediate medical assistance should be sought without inducing vomiting. This medication should be kept out of reach of children, and it is advisable not to transfer it to another container.
Side effects
Esophagitis
esophageal ulcer
esophageal erosion
esophageal obstruction
esophageal perforation
bleeding
dysphagia
odynophagia
retrosternal pain
heartburn
Show 40 moreCollapse
gastric ulcer
duodenal ulcer
abdominal pain
nausea
dyspepsia
constipation
diarrhea
flatulence
acid reflux
vomiting
abdominal distension
gastritis
musculoskeletal pain
muscle cramps
headache
dizziness
taste disturbance
rash
erythema
anastomotic ulcer
urticaria
angioedema
myalgia
symptoms of hypocalcemia
peripheral edema
oropharyngeal ulcer
localized jaw osteonecrosis
joint swelling
low-energy fracture of the femoral neck
dizziness
vertigo
itching
hair loss
Stevens-Johnson syndrome
toxic epidermal necrolysis
uveitis
scleritis
episcleritis
external auditory canal cholesteatoma
and nasopharyngitis
Not everyone experiences these, and they can vary from person to person.
Storage
This medication may be sensitive to air and moisture, so it must be stored in a sealed container. Additionally, it is best to keep it away from direct sunlight and at room temperature between 1°C and 30°C. Proper storage helps maintain the effectiveness of the medication for a longer period.
Appearance and packaging
Appearance
White to grayish rectangular tablets
Package unit
4 tablets (4 tablets/PTP × 1)
Same-ingredient medicines
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety. Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.